Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Ramucirumab + Pembrolizumab for Head and Neck Cancer
Recruiting1 awardPhase 1 & 2
Saint Louis, Missouri
This trial is testing the combination of two drugs to see if they are more effective than one of the drugs alone in treating head and neck cancer. The first part of the trial establishes the safety of the combination and the second part looks at its efficacy.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service